Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daria S. Osipova
Observed names:
D. S. Osipova,
D.S. Osipova,
Daria Osipova,
Осипова Д. С.
Institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institutions:
Ministry of Health of the Russian Federation,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0000-0002-9968-9332
Observed ORCID:
0000-0002-9968-9332
OpenAlex ID:
A5035868561
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH
2023
·
Dmitry Evseev
, Daria Osipova
, et al.
·
Blood Advances
·
41
PDF
CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality
2023
·
V. M. Ukrainskaya
, O. E. Musatova
, et al.
·
Scientific Reports
·
34
PDF
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA
2021
·
Dmitry Evseev
, Irina Kalinina
, et al.
·
International Journal of Hematology
·
33
PDF
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning
2024
·
Valeria M. Stepanova
, Dmitry V. Volkov
, et al.
·
Molecular Therapy Oncology
·
13
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients
2026
·
Jean Donadieu
, Dmitry Evseev
, et al.
·
Blood Advances
·
8
Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study
2022
·
Valeria Ukrainskaya
, Olga Molostova
, et al.
·
Blood Advances
·
8
Clinicogenomic associations in patients with Langerhans cell histiocytosis: a cohort study
2023
·
D. S. Osipova
, E. V. Raykina
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis
2026
·
Paul G. Kemps
, Jennifer L. Picarsic
, et al.
·
Blood Cancer Journal
·
1
PDF
Haploidentical donor regulatory T cells and memory T cells are safe and effective in children with refractory graft-versus-host disease with concurrent viral infections
2025
·
VictoryIa Vedmedskaia
, Dmitriy Pershin
, et al.
·
Blood
·
1
Approaches to the treatment of a multisystem form of juvenile xanthogranuloma with central nervous system lesion
2023
·
M. V. Natrusova
, E. A. Burtsev
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
1
PDF
The use of droplet digital polymerase chain reaction for the molecular diagnosis and monitoring of treatment response in patients with Langerhans cell histiocytosis with the BRAF V600E mutation
2023
·
D. S. Osipova
, E. V. Raykina
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Resistance to BRAF inhibitors in a patient with BRAF V600E-positive Langerhans cell histiocytosis
2023
·
E. I. Lyudovskikh
, D. A. Evseev
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Efficacy of Vemurafenib Combined With Cytarabine and 2-chloro-2′-deoxyadenosine as First-line Therapy in Children With Multisystem Langerhans Cell Histiocytosis
2026
·
E.A. Burtsev
, D.A. Evseev
, et al.
·
PEDIATRIA Journal named after G N SPERANSKY
Preclinical development of a protocol for the manufacturing of anti-CD5 CAR-T lymphocytes for the treatment of T-lineage acute lymphoblastic leukemia and lymphoma
2025
·
Elvira Y. Musaeva
, Ekaterina A. Malakhova
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
Experience in manufacturing a haploidentical biomedical cell product enriched with regulatory T-lymphocytes
2024
·
V. A. Vedmedskaia
, D. E. Pershin
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
The use of BRAF-inhibitors as monotherapy and in combination with cytosine arabinoside and 2-chloro-2’deoxyadenosine in pediatric patients with different forms of Langerhans cell histiocytosis
2024
·
E. A. Burtsev
, D. A. Evseev
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
PDF
The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with BRAFV600E mutation
2023
·
E. I. Lyudovskikh
, D. A. Yevseyev
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
Show more works
View as search
Works count:
18
Citation count:
144
H-index:
6
I10-index:
4
Year
Topic
Type